4.6 Article

Development of biomimetic triazine-based affinity ligands for efficient immunoglobulin G purification from human and rabbit plasma

Journal

JOURNAL OF CHROMATOGRAPHY A
Volume 1684, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.chroma.2022.463559

Keywords

Biomimetic ligand; Triazine-based affinity ligand; Immunoglobulin G

Funding

  1. Tabriz University of Medical Sciences
  2. [64847]

Ask authors/readers for more resources

The study focuses on the role of aryl substituents in triazine-based affinity ligands on the purification of immunoglobulin G (IgG). The findings suggest that using specific substituents can enhance the purification of IgG with high yield and purity.
Immunoglobulin purification from different biological fluids is considered one of the most critical steps in antibody production for diagnostic, therapeutic, and research purposes. The current study aimed to elucidate the role of the different aryl substituents in triazine-based affinity ligands on the performance of an affinity chromatography purification media to separate immunoglobulin G (IgG). The biomimetic triazine-based affinity ligand was chosen as a varied containing fix spacer and support. The sepharose beads were activated by epichlorohydrin, and five types of aryl substituents were replaced in the triazine ring and covalently immobilized to the resin surface by 1, 4-diaminobutane spacer. All affinity resins with various ligands were characterized and validated using FTIR, SEM, EDX, and microscopic images. The findings revealed that using R 1 = 3-aminophenol and R 2 = 3-aminophenol substituents in the triazine ring, as affinity ligands attached to the sepharose surface with a 10-atom linker CAES-6B-Cl@R1 = MAF, R2 = MAF (No. 4), leads to better purification of IgG from human and rabbit plasma with 22.8 mg/mL resin binding capacity in 73 +/- 5% yield and 95% of purity. All results confirmed that the designed triazine-based affinity ligands could effectively purify IgG compatible with a fast and low-cost approach. (c) 2022 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available